STOCK TITAN

[144] LIGAND PHARMACEUTICALS INC SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Form 144 notice for proposed sale of 10,000 common shares by an insider through Morgan Stanley Smith Barney LLC. The filing states the aggregate market value of the shares to be sold is $1,708,087.44 based on 10,000 shares, with approximately 19,596,560 shares outstanding for the issuer. The approximate date of sale is listed as 09/23/2025. The filer reports no securities sold in the past three months. Acquisition details show the 10,000 shares were acquired in multiple lots between 06/04/2022 and 06/06/2025 via restricted stock grants and exercised share transactions, with specific lot sizes and payment methods noted where applicable.

Avviso Form 144 per la vendita proposta di 10.000 azioni comuni da un insider tramite Morgan Stanley Smith Barney LLC. La richiesta riporta che il valore di mercato aggregato delle azioni da vendere è di 1.708.087,44 USD, basato su 10.000 azioni, con circa 19.596.560 azioni in circolazione dell'emittente. La data approssimativa di vendita è registrata come 23/09/2025. Il presentatore riferisce di non aver venduto titoli negli ultimi tre mesi. I dettagli di acquisizione mostrano che le 10.000 azioni sono state acquisite in più lotti tra il 04/06/2022 e il 06/06/2025 tramite contributi di azioni vincolate e transazioni di azioni esercitate, con dimensioni dei lotti specifiche e metodi di pagamento indicati dove applicabile.

Notificación Formulario 144 para la venta propuesta de 10,000 acciones comunes por un insider a través de Morgan Stanley Smith Barney LLC. La presentación indica que el valor de mercado agregado de las acciones a vender es de $1,708,087.44 basándose en 10,000 acciones, con aproximadamente 19,596,560 acciones en circulación para el emisor. La fecha aproximada de venta se indica como 23/09/2025. El presentador informa que no se han vendido valores en los últimos tres meses. Los detalles de adquisición muestran que las 10,000 acciones se adquirieron en múltiples lotes entre el 04/06/2022 y el 06/06/2025 mediante asignaciones de acciones restringidas y transacciones de acciones ejercidas, con tamaños de lote específicos y métodos de pago indicados cuando corresponde.

Form 144 내부자 매매 공지 Morgan Stanley Smith Barney LLC를 통해 제안된 10,000주 일반주 매각. 제출서에 따르면 매도될 주식의 총시장가치는 1,708,087.44달러이며, 10,000주를 기준으로 발행사 주식수는 약 19,596,560주입니다. 매각 예정일은 2025년 9월 23일로 기재되어 있습니다. 제출자는 지난 3개월 동안 증권이 매매되지 않았다고 보고합니다. 취득 세부사항은 10,000주가 2022년 6월 4일과 2025년 6월 6일 사이에 제한주 부여 및 행사주 거래를 통해 여러 로트로 취득되었으며, 해당될 경우 구체적인 로트 규모 및 지급 방법이 기재되어 있습니다.

Avis Form 144 sur la vente proposée de 10 000 actions ordinaires par un initié via Morgan Stanley Smith Barney LLC. Le dossier indique que la valeur marchande globale des actions à vendre est de 1 708 087,44 USD, sur la base de 10 000 actions, avec environ 19 596 560 actions en circulation pour l'émetteur. La date approximative de vente est inscrite comme étant le 23/09/2025. Le déclarant indique qu'aucun titre n'a été vendu au cours des trois derniers mois. Les détails d'acquisition montrent que les 10 000 actions ont été acquises en plusieurs lots entre le 04/06/2022 et le 06/06/2025 via des attributions d'actions restreintes et des transactions d'actions exercées, avec des tailles de lots spécifiques et des méthodes de paiement indiquées lorsque applicable.

Formular 144 Hinweis zum geplanten Verkauf von 10.000 Stammaktien durch einen Insider über Morgan Stanley Smith Barney LLC. Die Einreichung gibt an, dass der aggregierte Marktwert der zu verkaufenden Aktien 1.708.087,44 $ beträgt, basierend auf 10.000 Aktien, mit etwa 19.596.560 ausstehenden Aktien des Emittenten. Das voraussichtliche Verkaufsdatum wird mit dem 23.09.2025 angegeben. Der Antragsteller meldet, dass in den letzten drei Monaten keine Wertpapiere verkauft wurden. Die Erwerbsdaten zeigen, dass die 10.000 Aktien in mehreren Losen zwischen dem 04.06.2022 und dem 06.06.2025 über restrictierte Aktienzuteilungen und ausgeübte Aktientransaktionen erworben wurden, wobei, falls zutreffend, spezifische Losgrößen und Zahlungsmethoden vermerkt sind.

إشعار النموذج 144 للبيع المقترح لـ 10,000 سهمًا عاديًا من قبل مطلع عبر مورغان ستانلي سميث بارني LLC. تشير التقديم إلى أن القيمةMarket الإجمالية للأسهم المراد بيعها هي 1,708,087.44 دولارًا بناءً على 10,000 سهم، مع نحو 19,596,560 سهمًا قائماً للمصدر. تاريخ البيع التقريبي مدرج كـ 23/09/2025. المقدم يبلغ عن عدم بيع أي أسهم في الثلاثة أشهر الماضية. تظهر تفاصيل الاستحواذ أن 10,000 سهم تم الحصول عليها في عدة دفعات بين 04/06/2022 و06/06/2025 عبر منح أسهم مقيدة ومعاملات أسهم مُمَارَسَة، مع ذكر أحجام دفعات محددة وطرق الدفع عند الاقتضاء.

Form 144 通知:拟通过内线通过摩根士丹利史密斯巴尼 LLC 出售 10,000 股普通股。 文件显示拟出售的股票的总市值为 1,708,087.44 美元,基于 10,000 股,发行人流通股约为 19,596,560 股。 拟出售的日期大致为 2025/09/23。 申报人报告在过去三个月内未出售证券。 收购细节显示这 10,000 股在 2022/06/04 至 2025/06/06 之间通过限售股授予和行使股交易以多笔买入方式取得,若适用还注明了具体批次规模和付款方式。

Positive
  • Broker identified as Morgan Stanley Smith Barney LLC, enabling orderly execution
  • Full acquisition history disclosed with dates and lot sizes, including restricted stock and exercised shares
Negative
  • None.

Insights

TL;DR: Insider intends to sell 10,000 shares via a registered broker on 09/23/2025; acquisition history is disclosed.

The filing meets Rule 144 disclosure requirements by identifying the broker, number of shares, aggregate market value, and the approximate sale date. The table of acquisitions lists multiple restricted stock grants and exercised-share lots with dates and payment types, which supports the filer’s ability to sell under Rule 144 resale conditions. The absence of reported sales in the prior three months is explicitly stated. From a compliance perspective, the form appears complete for a proposed transaction notice.

TL;DR: Transaction is routine documentation of an insider sale; details on lot dates and payment types are included.

The filing provides specific lot-level acquisition information: restricted stock grants on 06/04/2022, 06/09/2023, 06/09/2024, 06/06/2025 and exercised shares on 03/05/2024 and 04/30/2024, with cash payment noted for exercised lots. A registered broker is named for execution. There are no disclosures of recent sales, litigation, or other qualifiers within this notice that would alter basic market impact assessment. The filing is informational and procedural.

Avviso Form 144 per la vendita proposta di 10.000 azioni comuni da un insider tramite Morgan Stanley Smith Barney LLC. La richiesta riporta che il valore di mercato aggregato delle azioni da vendere è di 1.708.087,44 USD, basato su 10.000 azioni, con circa 19.596.560 azioni in circolazione dell'emittente. La data approssimativa di vendita è registrata come 23/09/2025. Il presentatore riferisce di non aver venduto titoli negli ultimi tre mesi. I dettagli di acquisizione mostrano che le 10.000 azioni sono state acquisite in più lotti tra il 04/06/2022 e il 06/06/2025 tramite contributi di azioni vincolate e transazioni di azioni esercitate, con dimensioni dei lotti specifiche e metodi di pagamento indicati dove applicabile.

Notificación Formulario 144 para la venta propuesta de 10,000 acciones comunes por un insider a través de Morgan Stanley Smith Barney LLC. La presentación indica que el valor de mercado agregado de las acciones a vender es de $1,708,087.44 basándose en 10,000 acciones, con aproximadamente 19,596,560 acciones en circulación para el emisor. La fecha aproximada de venta se indica como 23/09/2025. El presentador informa que no se han vendido valores en los últimos tres meses. Los detalles de adquisición muestran que las 10,000 acciones se adquirieron en múltiples lotes entre el 04/06/2022 y el 06/06/2025 mediante asignaciones de acciones restringidas y transacciones de acciones ejercidas, con tamaños de lote específicos y métodos de pago indicados cuando corresponde.

Form 144 내부자 매매 공지 Morgan Stanley Smith Barney LLC를 통해 제안된 10,000주 일반주 매각. 제출서에 따르면 매도될 주식의 총시장가치는 1,708,087.44달러이며, 10,000주를 기준으로 발행사 주식수는 약 19,596,560주입니다. 매각 예정일은 2025년 9월 23일로 기재되어 있습니다. 제출자는 지난 3개월 동안 증권이 매매되지 않았다고 보고합니다. 취득 세부사항은 10,000주가 2022년 6월 4일과 2025년 6월 6일 사이에 제한주 부여 및 행사주 거래를 통해 여러 로트로 취득되었으며, 해당될 경우 구체적인 로트 규모 및 지급 방법이 기재되어 있습니다.

Avis Form 144 sur la vente proposée de 10 000 actions ordinaires par un initié via Morgan Stanley Smith Barney LLC. Le dossier indique que la valeur marchande globale des actions à vendre est de 1 708 087,44 USD, sur la base de 10 000 actions, avec environ 19 596 560 actions en circulation pour l'émetteur. La date approximative de vente est inscrite comme étant le 23/09/2025. Le déclarant indique qu'aucun titre n'a été vendu au cours des trois derniers mois. Les détails d'acquisition montrent que les 10 000 actions ont été acquises en plusieurs lots entre le 04/06/2022 et le 06/06/2025 via des attributions d'actions restreintes et des transactions d'actions exercées, avec des tailles de lots spécifiques et des méthodes de paiement indiquées lorsque applicable.

Formular 144 Hinweis zum geplanten Verkauf von 10.000 Stammaktien durch einen Insider über Morgan Stanley Smith Barney LLC. Die Einreichung gibt an, dass der aggregierte Marktwert der zu verkaufenden Aktien 1.708.087,44 $ beträgt, basierend auf 10.000 Aktien, mit etwa 19.596.560 ausstehenden Aktien des Emittenten. Das voraussichtliche Verkaufsdatum wird mit dem 23.09.2025 angegeben. Der Antragsteller meldet, dass in den letzten drei Monaten keine Wertpapiere verkauft wurden. Die Erwerbsdaten zeigen, dass die 10.000 Aktien in mehreren Losen zwischen dem 04.06.2022 und dem 06.06.2025 über restrictierte Aktienzuteilungen und ausgeübte Aktientransaktionen erworben wurden, wobei, falls zutreffend, spezifische Losgrößen und Zahlungsmethoden vermerkt sind.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 for LGNZZ disclose about the proposed sale?

The form discloses a proposed sale of 10,000 common shares with an aggregate market value of $1,708,087.44, executed through Morgan Stanley Smith Barney LLC on approximately 09/23/2025.

How many shares outstanding does the filing report for the issuer?

The filing reports 19,596,560 shares outstanding for the issuer.

Were any shares sold in the past three months according to the Form 144?

The filing states Nothing to Report for securities sold during the past three months.

What types of acquisitions are listed for the shares being sold?

Acquisitions include multiple restricted stock grants (06/04/2022; 06/09/2023; 06/09/2024; 06/06/2025) and exercised share transactions (03/05/2024; 04/30/2024), with exercised lots paid in cash where noted.

Who is the named broker for the proposed sale on Form 144?

The named broker is Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004.
Ligand Pharma

NASDAQ:LGND

LGND Rankings

LGND Latest News

LGND Latest SEC Filings

LGND Stock Data

3.25B
19.14M
2.3%
100.29%
5.93%
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN DIEGO